Edinburgh AMR Forum Lecture: Inventing an anti-infective drug The Edinburgh AMR Forum and the Fleming Fund Fellowship schemes, are pleased to invite you to join this lecture - Inventing an anti-infective drug - with Dr Maneesh Paul., CEO of Microvioma Private Limited.Dr Paul is the lead co-inventor of Enmetazobactam – the first invented-in-India anti-infective to be approved by USFDA.Dr Paul wil be hosted by Prof Till Bachmann, AMR Strategy lead for Edinburgh Infectious Diseases and co-Director of the Fleming Fund Felllowship Schemes at the University. Meeting with Dr Paul There will an opportunity to meet with Dr Paul informally over coffee before his talk, and to have 1:1 meetings later in the morning. If you would like to have a meeting please contact Till. Email Till Bachmann Programme 9.00 - 10.00 Coffee, introductions, networking10.00 - 11.00 Lecture About the speaker Since 2006, as its Program Director at Orchid Pharma, Chennai, Dr Maneesh Paul-Satyaseela led the inventionof Enmetazobactam as a biologist (along with medicinal chemist Senthilkumar UP), and is continuing to drive its approval and Phase-4 studies in India.Maneesh trained at MAHE & Kalaburagi Univ. (India), CBER-USFDA (ORISE Fellow), Johns Hopkins Medical Institutions (Peds ID), USA & at Umea Univ. Sweden (ID). He has nearly 40 publications and 5 Co-Inventions (patented) to his credit.He is one of the few non-clinicians in India to be conferred with the Fellow of Infectious Diseases Society of America (FIDSA).He serves as a member of UKRI’s Strategic Advisory Committee on PACE (2024-2029), Revive of GARDP, and three Biotech & skills Steering committees of local Government (in India); was on IDSA’s Research (2017-19, 2023-24), and AMR Committees (2019-22). In Bengaluru (India), he has led trans-disciplinary research at Acharya Institutions, post-graduate medical research in 7 clinical disciplines at St. Martha’s Hospital and was a clinical microbiologist at KIMS.An AMR steward, techno-commercial enabler, influencer, inventor, & an innovator with broad research expertise in mechanisms of infectious diseases, he currently provides Advisory solutions to several organizations in microbiology & anti-infectives, and promotes planetary health & antimicrobial stewardship through AMRACE (AMR Action Collaborative Engagement).Links: Website | LinkedIn | X | Instagram Mar 21 2025 09.00 - 11.00 Edinburgh AMR Forum Lecture: Inventing an anti-infective drug Dr Maneesh Paul will discuss the drug development process of Enmetazobactam, from discovery to regulatory approval. Room 2.35 Edinburgh Futures Institute, The University of Edinburgh Register on Eventbrite
Edinburgh AMR Forum Lecture: Inventing an anti-infective drug The Edinburgh AMR Forum and the Fleming Fund Fellowship schemes, are pleased to invite you to join this lecture - Inventing an anti-infective drug - with Dr Maneesh Paul., CEO of Microvioma Private Limited.Dr Paul is the lead co-inventor of Enmetazobactam – the first invented-in-India anti-infective to be approved by USFDA.Dr Paul wil be hosted by Prof Till Bachmann, AMR Strategy lead for Edinburgh Infectious Diseases and co-Director of the Fleming Fund Felllowship Schemes at the University. Meeting with Dr Paul There will an opportunity to meet with Dr Paul informally over coffee before his talk, and to have 1:1 meetings later in the morning. If you would like to have a meeting please contact Till. Email Till Bachmann Programme 9.00 - 10.00 Coffee, introductions, networking10.00 - 11.00 Lecture About the speaker Since 2006, as its Program Director at Orchid Pharma, Chennai, Dr Maneesh Paul-Satyaseela led the inventionof Enmetazobactam as a biologist (along with medicinal chemist Senthilkumar UP), and is continuing to drive its approval and Phase-4 studies in India.Maneesh trained at MAHE & Kalaburagi Univ. (India), CBER-USFDA (ORISE Fellow), Johns Hopkins Medical Institutions (Peds ID), USA & at Umea Univ. Sweden (ID). He has nearly 40 publications and 5 Co-Inventions (patented) to his credit.He is one of the few non-clinicians in India to be conferred with the Fellow of Infectious Diseases Society of America (FIDSA).He serves as a member of UKRI’s Strategic Advisory Committee on PACE (2024-2029), Revive of GARDP, and three Biotech & skills Steering committees of local Government (in India); was on IDSA’s Research (2017-19, 2023-24), and AMR Committees (2019-22). In Bengaluru (India), he has led trans-disciplinary research at Acharya Institutions, post-graduate medical research in 7 clinical disciplines at St. Martha’s Hospital and was a clinical microbiologist at KIMS.An AMR steward, techno-commercial enabler, influencer, inventor, & an innovator with broad research expertise in mechanisms of infectious diseases, he currently provides Advisory solutions to several organizations in microbiology & anti-infectives, and promotes planetary health & antimicrobial stewardship through AMRACE (AMR Action Collaborative Engagement).Links: Website | LinkedIn | X | Instagram Mar 21 2025 09.00 - 11.00 Edinburgh AMR Forum Lecture: Inventing an anti-infective drug Dr Maneesh Paul will discuss the drug development process of Enmetazobactam, from discovery to regulatory approval. Room 2.35 Edinburgh Futures Institute, The University of Edinburgh Register on Eventbrite
Mar 21 2025 09.00 - 11.00 Edinburgh AMR Forum Lecture: Inventing an anti-infective drug Dr Maneesh Paul will discuss the drug development process of Enmetazobactam, from discovery to regulatory approval.
